| Marathon Health At Draper Peaks | |
|
131 E 12300 S Ste R400 Draper UT 84020-4102 | |
| (802) 857-4000 | |
| Not Available |
| Full Name | Marathon Health At Draper Peaks |
|---|---|
| Speciality | Clinic/center - Primary Care |
| Location | 131 E 12300 S Ste R400, Draper, Utah |
| Authorized Official Name and Position | Jeff Wells (CEO) |
| Authorized Official Contact | 8028570400 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Marathon Health At Draper Peaks 20 Winooski Falls Way Ste 400 Winooski VT 05404-2239 Ph: (802) 857-0400 | Marathon Health At Draper Peaks 131 E 12300 S Ste R400 Draper UT 84020-4102 Ph: (802) 857-4000 |
| NPI Number | 1841938669 |
|---|---|
| Provider Enumeration Date | 05/23/2022 |
| Last Update Date | 06/22/2022 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841938669 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QP2300X | Clinic/center - Primary Care | (* (Not Available)) | Primary |
News Archive
The new payment rates for private Medicare Advantage plans - expected to be announced Friday - are likely to become political fodder in the midterm elections, reports Politico. Meanwhile, congressional Republicans come out against proposed changes in the Medicare prescription drug program which they say would increase seniors' costs.
EpiCept Corporation has announced that it has filed a New Drug Submission (NDS) with Health Canada for Ceplene® (histamine dihydrochloride) for the treatment of acute myeloid leukemia (AML) patients in first complete remission. Health Canada typically accepts or refuses an NDS and designates review status within forty-five days of filing. If accepted, the customary timeframe for completion of review and an approval decision is within one year.
A fundamental question pursued by plant scientists worldwide for the past decade has been answered by researchers led by the University of Sydney in Australia.
Genentech, Inc., a wholly owned member of the Roche Group, and Biogen Idec announced today the U.S. Food and Drug Administration (FDA) approved Rituxan® (rituximab) in combination with fludarabine and cyclophosphamide (FC) for people with previously untreated and previously treated CD20-positive chronic lymphocytic leukemia (CLL).
› Verified 2 days ago
My Family Doctor Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 877 E 12300 S, Suite 201, Draper, UT 84020 Phone: 801-542-7111 Fax: 801-542-7112 | |
Spencer J Hardenbrook Md Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 12176 S 1000 E, Draper, UT 84020 Phone: 800-640-3451 Fax: 801-572-1097 | |
Wasathc Health Solutions Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1135 Parkstone Dr, Draper, UT 84020 Phone: 801-641-3686 Fax: 801-545-8744 | |
Hidden Valley Family Medicine Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 12176 S 1000 E, Draper, UT 84020 Phone: 801-572-3750 Fax: 801-572-1097 | |
Granger Medical Specialists Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 96 E Kimballs Ln Ste 304, Draper, UT 84020 Phone: 801-571-9433 | |
Lone Peak Medical Associates Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 14768 S Dryburg Cv, Draper, UT 84020 Phone: 801-558-5126 Fax: 801-206-3823 | |
Landmark Medical Of Utah, Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 12921 S Vista Station Blvd, Draper, UT 84020 Phone: 657-400-5180 |